| Name | Author | |
|
Since the 1950s, global pharmaceutical companies have invested billions of dollars in safety and monitoring systems to improve pharmacovigilance. Despite the tremendous expenditure of time and resources, the industry continues to experience unforeseen saf…
|
Uwe Maennl |
|
A changing regulatory environment and difficult targets present significant challenges for biopharmaceutical companies seeking a balanced approach to risk management.
|
Nayan Nanavati, Vice President, Peri-Approval Clinical Excellence, Americas |
|
In the current competitive global market, you need uncomplicated access to a comprehensive breadth of services no matter your company size, global needs or therapeutic focus.
|
|
|
Proactive risk management helps pharma protect their product development investments and futures. Proactive risk management is absolutely vital for every organization in today's fast moving global marketplace. As the recent worldwide financial crisis clea…
|
Holger Liebig and Rebecca Hastings |
|
In today’s complex and competitive healthcare arena,
receiving approval by the Food and Drug Administration
(FDA) is just one of the many hurdles that a biopharmaceutical
company must overcome to achieve commercial
success for a new drug or medical device…
|
Charles A. Stevens |